Clinical trial
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
NCT05102799 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 1, 2021
- Completion date
- August 1, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
limb girdle muscular dystrophy